BIO (BIO)

Financial Metrics & Valuation Analysis

Enterprise Valuation (TTM)

Enterprise Value$9.67B
EV / Sales3.73
EV / EBITDA20.59
EV / Operating Cash Flow18.95
EV / Free Cash Flow27.07

Return Metrics (TTM)

Return on Equity (ROE)2.40%
Return on Assets (ROA)1.72%
Return on Invested Capital (ROIC)1.95%
Return on Capital Employed (ROCE)2.70%

Yield Metrics

Earnings Yield1.92%
Free Cash Flow Yield4.06%

Balance Sheet Strength

Net Debt / EBITDA1.85
Current Ratio3.21
Working Capital$2.03B
Tangible Asset Value$6.11B
Net Current Asset Value$3.40M

Working Capital Efficiency

Days Sales Outstanding60.07
Days Payables Outstanding38.97
Operating Cycle (Days)285.66
Cash Conversion Cycle246.69

Capital Allocation

CapEx / Revenue5.92%
CapEx / Operating Cash Flow30.02%
R&D / Revenue10.05%
SG&A / Revenue32.57%

Fiscal Year 2025 Ratios

Audited annual results as of 2025-12-31

Margins

Gross Profit Margin52.01%
Operating Margin10.47%
Net Profit Margin29.42%

Solvency

Debt / Equity0.21
Quick Ratio4.19
Cash Ratio1.03

Per Share

Revenue / Share$94.75
FCF / Share$13.74
PE Ratio10.87